{"timestamp": 1771602730.3346424, "value": {"ticker": "LRMR", "company_name": "Larimar Therapeutics, Inc.", "short_name": "Larimar Therapeutics, Inc.", "sector": "Healthcare", "industry": "Biotechnology", "country": "United States", "market_cap": 256771168, "float_shares": 41945283, "shares_outstanding": 83090392, "short_ratio": 7.17, "short_percent_of_float": 0.161, "shares_short": 8765467, "shares_short_prior": 8240719, "insider_percent_held": 0.01102, "institution_percent_held": 0.88031, "total_cash": 175435008, "total_debt": 4347000, "total_revenue": 0, "revenue_growth": 0, "earnings_growth": 0, "profit_margins": 0.0, "gross_margins": 0.0, "operating_margins": 0.0, "debt_to_equity": 3.126, "current_ratio": 4.061, "book_value": 1.624, "price_to_book": 1.8472906, "operating_cashflow": -96489000, "free_cashflow": -48963500, "price": 3.0, "52w_high": 5.37, "52w_low": 1.61, "avg_volume": 1245136, "avg_volume_10d": 850120, "full_time_employees": 65, "audit_risk": 7, "overall_risk": 8}}